SA
Sulaiman Alhabib Stock: price and insider trades · Saudi Arabia
Sulaiman Alhabib: what insiders have been doing
Sulaiman Alhabib has a thin disclosure history in our data (latest filing: 8 October 2023). New filings will appear here as soon as they are published. This summary is built from Tadawul (CMA) disclosures alone and does not predict where the share price will go.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Analyst consensus: bullish or bearish?
Analysts rate Sulaiman Alhabib Buy (bullish), based on 15 analysts. Average price target: SAR 265.65.
Fundamental score
Ranked 13,377 of 26,913 companies
51.6
score / 100
Value37
Quality66
FCF yld0.6%
Earn yld3.2%
EV/EBITDA24.0x
ROE30%
Gross mgn31%
Net mgn18%
Debt/EBITDA2.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SAR 215.80
Analyst consensus
15 analystsBuy
SAR 183.00Target SAR 265.65(+23%)SAR 310.00
Income statement
RevenueSAR 13.7B
Gross profitSAR 4.2B31% margin
EBITDASAR 3.5B26% margin
Net incomeSAR 2.4B16.4% margin
Valuation
PER (trailing)30.2x
PER (forward)24.6x
P/Book8.9x
Beta0.04
Balance sheet & cash
Market capSAR 75.5B
Total debtSAR 9.3B
Free Cash FlowSAR 418.6M
Debt / Equity106%
Profitability & ownership
ROE30.4%
ROA7.4%
% insiders70.9%
% institutions4.5%
Last declaration on 8 October 2023
Declarations3 total
- ●Executives0Tadawul
- ●Executives0Tadawul
- ●Executives0Tadawul
3 of 3 declarations
About Sulaiman Alhabib
Sulaiman Alhabib is a company operating in the healthcare and pharmaceutical sector. It is listed on the XSAU market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations